Galaczym

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGalaczym
Drug Alias Nameenzyme replacement therapy (Zymenex)
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionGalactocerebrosidase stimulants
TargetsGalactocerebrosidase
Therapy Area/IndicationsLeukodystrophy, Globoid Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWorld
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZymenex As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZymenex AsAce Biosciences
Active IndicationsN/A
Inactive IndicationsLeukodystrophy, Globoid Cell

Other Information

ATC CodeN/A
Related LinksN/A